Yuling Han, Xiaohua Duan, Liuliu Yang, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270-275. doi:10.1038/s41586-020-2901-9
Hongbing Wang, Paul C. Brown, Edwin C. Y. Chow, et al. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clinical and Translational Science. 2021;14(5):1659-1680. doi:10.1111/cts.13066
Michael S. Lauer, Jamie Doyle, Joy Wang, Deepshikha Roychowdhury. Associations of topic-specific peer review outcomes and institute and center award rates with funding disparities at the National Institutes of Health. eLife. 2021;10:e67173. doi:10.7554/eLife.67173
Marissa M. Shams-White, Rolando Barajas, Roxanne E. Jensen, et al. Systems epidemiology and cancer: A review of the National Institutes of Health extramural grant portfolio 2013-2018. PloS One. 2021;16(4):e0250061. doi:10.1371/journal.pone.0250061
Talia H. Swartz, Ann-Gel S. Palermo, Sandra K. Masur, Judith A. Aberg. The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and Diversity. The Journal of Infectious Diseases. 2019;220(S2):S33-S41. doi:10.1093/infdis/jiz174
Kathy Archibald, Katya Tsaioun, J. Gerry Kenna, Pandora Pound. Better science for safer medicines: the human imperative. Journal of the Royal Society of Medicine. 2018;111(12):433-438. doi:10.1177/0141076818812783
Joseph A. DiMasi, Henry G. Grabowski, Ronald W. Hansen. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics. 2016;47:20-33. doi:10.1016/j.jhealeco.2016.01.012
Donna K. Ginther, Walter T. Schaffer, Joshua Schnell, et al. Race, ethnicity, and NIH research awards. Science. 2011;333(6045):1015-1019. doi:10.1126/science.1196783